P032-2721 Screening compound: 2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]-N-[(oxolan-2-yl)methyl]acetamide

P032-2721 Screening compound: 2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]-N-[(oxolan-2-yl)methyl]acetamide
P032-2721 Screening compound: 2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]-N-[(oxolan-2-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P032-2721
2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]-N-[(oxolan-2-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P032-2721

Molecular Formula

C20H23N5O4 (C20 H23 N5 O4)

Compound Name

2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]-N-[(oxolan-2-yl)methyl]acetamide

IUPAC name

2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H3H-[124]triazolo[43-c]pyrimidin-2-yl]-N-[(oxolan-2-yl)methyl]acetamide

SMILES

CC(N12)=NC(c(cc3)ccc3OC)=CC2=NN(CC(NCC2OCCC2)=O)C1=O

InChI

InChI=1S/C20H23N5O4/c1-13-22-17(14-5-7-15(28-2)8-6-14)10-18-23-24(20(27)25(13)18)12-19(26)21-11-16-4-3-9-29-16/h5-8,10,16H,3-4,9,11-12H2,1-2H3,(H,21,26)/t16-/m1/s1

InChI Key

UDMWRMXYRKGQDS-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD27559361

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

397.43

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.055

Distribution Coefficient, logD

1.047

Water Solubility, LogSw

-2.11

Polar Surface Area

81.659

Acid Dissociation Constant (pKa)

15.01

Base Dissociation Constant (pKb)

5.67

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.00

P032-2721 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with P032-2721 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P032-2721?
Check Price and Availability of P032-2721, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P032-2721 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P032-2721
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P032-2721
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P032-2721 available by request